2009
DOI: 10.1021/jf8034786
|View full text |Cite
|
Sign up to set email alerts
|

Galactooligosaccharides (GOS) Inhibit Vibrio cholerae Toxin Binding to Its GM1 Receptor

Abstract: It is widely reported that cholera toxin (Ctx) remains a significant cause of gastrointestinal disease globally, particularly in developing countries where access to clean drinking water is at a premium. Vaccines are prohibitively expensive and have shown only short-term protection. Consequently, there is scope for continued development of novel treatment strategies. One example is the use of galactooligosaccharides (GOS) as functional mimics for the cell-surface toxin receptor (GM1). In this study, GOS fracti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
30
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(32 citation statements)
references
References 40 publications
(56 reference statements)
0
30
1
Order By: Relevance
“…The presence of these glycans in human milk has been shown to reduce the risk of diarrhea as well as the incidence of respiratory diseases (72). Similarly, GOS has been shown to display antiadhesive properties against enteropathogenic E. coli, Salmonella, Vibrio cholera toxin binding and Chronobacter sakazakii (73)(74)(75)(76).…”
Section: Colonization Resistance To Pathogens Induced By the Colonic mentioning
confidence: 99%
“…The presence of these glycans in human milk has been shown to reduce the risk of diarrhea as well as the incidence of respiratory diseases (72). Similarly, GOS has been shown to display antiadhesive properties against enteropathogenic E. coli, Salmonella, Vibrio cholera toxin binding and Chronobacter sakazakii (73)(74)(75)(76).…”
Section: Colonization Resistance To Pathogens Induced By the Colonic mentioning
confidence: 99%
“…Specifically, GOS supplements have been shown to exert positive impacts on intestinal Bifidobacterium and Lactobacillus populations in infants (11), to mitigate irritated bowel syndrome (12), and to reduce the severity and duration of travelers' diarrhea (13). GOS has also been shown to inhibit pathogenic Vibrio cholerae and Cronobacter sakazakii binding to cell surface receptors of epithelial cells (14,15) and prevent adhesion of Salmonella enterica serovar Typhimurium to murine enterocytes (16).…”
mentioning
confidence: 99%
“…Examples include the inhibition of Salmonella, enteropathogenic E. coli, Cronobacter sakazakii and Vibrio cholerae toxin adherence to epithelial cells and cell surface receptors [31][32][33][34]. In contrast, PDX did not inhibit lectin attachment, suggesting that it is not effective as an adherence inhibition agent.…”
Section: Discussionmentioning
confidence: 99%